Morning Briefing
Summaries of health policy coverage from major news organizations
Gilead Becomes First Company To License Drugs To Medicines Patent Pool
"In the first agreement between a pharmaceutical company and the new international Medicines Patent Pool, Gilead Sciences announced Tuesday that it would license four of its AIDS and hepatitis B drugs to the pool," the New York Times reports (McNeil, 7/12).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
